Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2017 Filed Feb 22, 2017 23:47 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Exercise / conversionHumana Common | 10,651 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000030 · edgar.xml · nonDerivative · entry 1 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: Includes both time based (3,304) and performance based (7,347) restricted stock units that vested on 2/18/2017. Read SEC document |
| February 18, 2017 Filed Feb 22, 2017 23:43 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 16,519 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 16,519 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 02/18/2014, 100% of the award is vesting on 02/18/17. F6 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 02/18/2014, 100% of the award is vesting on 02/18/17. Read SEC document |
| February 18, 2017 Filed Feb 22, 2017 23:43 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Tax withholdingHumana Common | 25,413 | $205.33 | $5,217,924.23 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,695 Read SEC document |
| February 18, 2017 Filed Feb 22, 2017 23:43 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 53,257 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: Includes both time based (16,519) and performance based (36,738) based restricted stock units that vested on 2/18/17. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 18:48 UTC |
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 14,827 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000011 · edgar.xml · derivative · entry 6 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 14,827 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan. F5 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 01/06/14, 100% of the award is vesting on 01/06/17. F5 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 01/06/14, 100% of the award is vesting on 01/06/17. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 18:48 UTC |
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
|
Tax withholdingHumana Common | 6,576 | $201.25 | $1,323,436.44 |
DisclosureSEC source: 0000049071-17-000011 · edgar.xml · nonDerivative · entry 2 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,966 Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 18:48 UTC |
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
|
Exercise / conversionHumana Common | 14,827 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000011 · edgar.xml · nonDerivative · entry 1 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:49 UTC |
Dunbar Webster RoyDirector
|
GrantHumana Common | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000009 · edgar.xml · nonDerivative · entry 1 Dunbar Webster Roy · CIK 0001305807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,166 F4 · balance_after: Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:47 UTC |
OBRIEN JAMES J /KYDirector
|
GrantHumana Common | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000008 · edgar.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,361 F3 · balance_after: Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:45 UTC |
MITCHELL WILLIAMDirector
|
GrantRestricted Stock Units · Derivative | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000007 · edgar.xml · derivative · entry 4 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761 Underlying: Humana Common · 761 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:38 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000006 · edgar.xml · derivative · entry 5 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761 Underlying: Humana Common · 761 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:34 UTC |
PETERSON MARISSA TDirector
|
GrantHumana Common | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000005 · edgar.xml · nonDerivative · entry 1 PETERSON MARISSA T · CIK 0001220067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,066 F3 · balance_after: Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:31 UTC |
NASH DAVIDDirector
|
GrantRestricted Stock Units · Derivative | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000004 · edgar.xml · derivative · entry 4 NASH DAVID · CIK 0001251968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761 Underlying: Humana Common · 761 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:21 UTC |
JONES DAVID A JR/KYDirector
|
GrantHumana Common | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000003 · edgar.xml · nonDerivative · entry 1 JONES DAVID A JR/KY · CIK 0001025393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761 F8 · balance_after: Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:18 UTC |
DAMELIO FRANK ADirector
|
GrantRestricted Stock Units · Derivative | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000002 · edgar.xml · derivative · entry 7 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761 Underlying: Humana Common · 761 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:11 UTC |
McDonald William J.Director
|
GrantRestricted Stock Units · Derivative | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000001 · edgar.xml · derivative · entry 5 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761 Underlying: Humana Common · 761 shares Expires not disclosed F1 · derivative.exercise_price: Annual Director's fee payable in stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2011 Plan.100% of the award is vesting on 12/31/2017. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2011 Plan.100% of the award is vesting on 12/31/2017. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2011 Plan.100% of the award is vesting on 12/31/2017. Read SEC document |
| January 02, 2017 Filed Jan 3, 2018 21:11 UTC |
MITCHELL WILLIAMDirector
|
GrantRestricted Stock Units · Derivative | 658 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000010 · edgar.xml · derivative · entry 4 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658 Underlying: Humana Common · 658 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. Read SEC document |
| January 02, 2017 Filed Jan 3, 2018 20:59 UTC |
DAMELIO FRANK ADirector
|
GrantStock Unit · Derivative | 658 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000005 · edgar.xml · derivative · entry 7 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658 Underlying: Humana Common · 658 shares Expires not disclosed F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:52 UTC |
MURRAY JAMES EEVP & COO
|
OtherPhantom Stock Units · Derivative | 6 | $171.06 | $1,026.36 |
DisclosureSEC source: 0000049071-17-000010 · edgar.xml · derivative · entry 12 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,808 Underlying: Humana Common · 6 shares Expires not disclosed F11 · security: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. F11 · derivative.exercise_price: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. F11 · derivative.exercise_date: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. F11 · derivative.expiration_date: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. F11 · ownership.nature: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:49 UTC |
Dunbar Webster RoyDirector
|
GrantStock Unit · Derivative | 132 | $203.53 | $26,865.96 |
DisclosureSEC source: 0000049071-17-000009 · edgar.xml · derivative · entry 4 Dunbar Webster Roy · CIK 0001305807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 842 Underlying: Humana Common · 132 shares Expires not disclosed F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:45 UTC |
MITCHELL WILLIAMDirector
|
GrantStock Unit · Derivative | 91 | $203.53 | $18,521.23 |
DisclosureSEC source: 0000049071-17-000007 · edgar.xml · derivative · entry 3 MITCHELL WILLIAM · CIK 0001187421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 789 Underlying: Humana Common · 91 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:38 UTC |
HILZINGER KURT JDirector
|
GrantStock Unit · Derivative | 376 | $203.53 | $76,527.28 |
DisclosureSEC source: 0000049071-17-000006 · edgar.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,824 Underlying: Humana Common · 376 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:38 UTC |
HILZINGER KURT JDirector
|
GrantStock Unit · Derivative | 144 | $203.53 | $29,308.32 |
DisclosureSEC source: 0000049071-17-000006 · edgar.xml · derivative · entry 3 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689 Underlying: Humana Common · 144 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:31 UTC |
NASH DAVIDDirector
|
GrantStock Unit · Derivative | 71 | $203.53 | $14,450.63 |
DisclosureSEC source: 0000049071-17-000004 · edgar.xml · derivative · entry 3 NASH DAVID · CIK 0001251968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420 Underlying: Humana Common · 71 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:11 UTC |
McDonald William J.Director
|
GrantStock Unit · Derivative | 143 | $203.53 | $29,104.79 |
DisclosureSEC source: 0000049071-17-000001 · edgar.xml · derivative · entry 4 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 785 Underlying: Humana Common · 143 shares Expires not disclosed F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:11 UTC |
McDonald William J.Director
|
GrantStock Unit · Derivative | 153 | $203.53 | $31,140.09 |
DisclosureSEC source: 0000049071-17-000001 · edgar.xml · derivative · entry 3 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,846 Underlying: Humana Common · 153 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 18:11 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
Exercise / conversionOptions · Derivative | 4,971 | $0.00 Strike: $164.65 | $0.00 |
DisclosureSEC source: 0000049071-16-000203 · edgar.xml · derivative · entry 7 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,942 Underlying: Humana Common · 4,971 shares Expires 2022-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. F3 · derivative.exercise_date: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 18:11 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
Exercise / conversionOptions · Derivative | 4,842 | $0.00 Strike: $102.16 | $0.00 |
DisclosureSEC source: 0000049071-16-000203 · edgar.xml · derivative · entry 6 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,422 Underlying: Humana Common · 4,842 shares Expires 2021-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17. F2 · derivative.exercise_date: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 18:11 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
Exercise / conversionOptions · Derivative | 1,936 | $0.00 Strike: $72.84 | $0.00 |
DisclosureSEC source: 0000049071-16-000203 · edgar.xml · derivative · entry 5 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 1,936 shares Expires 2020-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to Humana Inc.'s 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/20/13, vesting in three increments from 02/20/14 to 02/20/16. F1 · derivative.exercise_date: Right to buy pursuant to Humana Inc.'s 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/20/13, vesting in three increments from 02/20/14 to 02/20/16. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 18:11 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
Tax withholdingHumana Common | 9,061 | $200.81 | $1,819,494.11 |
DisclosureSEC source: 0000049071-16-000203 · edgar.xml · nonDerivative · entry 4 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,371 F8 · price: The total amount of shares withheld for taxes and swapped for purchase price is 9,061. The amount of shares required for swap on purchase price for shares exercised under the Company's 2011 Stock Incentive Plan was determined using a Fair Market Value ("FMV") of $199.84 on 12/21/2016, pursuant to the Plan. All shares withheld for taxes and shares required for swap under the Company's 2003 Stock Incentive Plan were determined using the FMV on 12/22/2016 $200.8050, pursuant to each Plan. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 18:11 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
Exercise / conversionHumana Common | 4,971 | $164.65 | $818,450.30 |
DisclosureSEC source: 0000049071-16-000203 · edgar.xml · nonDerivative · entry 3 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 18:11 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
Exercise / conversionHumana Common | 4,842 | $102.16 | $494,634.51 |
DisclosureSEC source: 0000049071-16-000203 · edgar.xml · nonDerivative · entry 2 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 18:11 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
Exercise / conversionHumana Common | 1,936 | $72.84 | $141,018.24 |
DisclosureSEC source: 0000049071-16-000203 · edgar.xml · nonDerivative · entry 1 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 14:57 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Exercise / conversionOptions · Derivative | 8,500 | $0.00 Strike: $81.80 | $0.00 |
DisclosureSEC source: 0000049071-16-000202 · edgar.xml · derivative · entry 3 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,581 Underlying: Humana Common · 8,500 shares Expires 2020-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 06/17/13, vesting in three increments from 06/17/14 to 06/17/16. F1 · derivative.exercise_date: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 06/17/13, vesting in three increments from 06/17/14 to 06/17/16. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 14:57 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Tax withholdingHumana Common | 5,972 | $201.26 | $1,201,924.72 |
DisclosureSEC source: 0000049071-16-000202 · edgar.xml · nonDerivative · entry 2 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,788 F8 · price: The total amount of shares withheld for taxes and swapped for purchase price is 5,960. The amount of shares required for swap on purchase price for shares exercised under the Company's 2011 Stock Incentive Plan was determined using a Fair Market Value ("FMV") of $202.9150 on 12/19/2016, pursuant to the Plan. Shares withheld for taxes was determined using the FMV on 12/20/2016 ($201.260), pursuant to the Plan. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 14:57 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Exercise / conversionHumana Common | 8,500 | $81.80 | $695,257.50 |
DisclosureSEC source: 0000049071-16-000202 · edgar.xml · nonDerivative · entry 1 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:21 UTC |
LeClaire Brian P.SVP & Chief Information Off.
|
Exercise / conversionRestricted Stock Units · Derivative | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000200 · edgar.xml · derivative · entry 9 LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,186 Underlying: Humana Common · 1,092 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:21 UTC |
LeClaire Brian P.SVP & Chief Information Off.
|
Tax withholdingHumana Common | 548 | $206.60 | $113,214.06 |
DisclosureSEC source: 0000049071-16-000200 · edgar.xml · nonDerivative · entry 2 LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,845 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:21 UTC |
LeClaire Brian P.SVP & Chief Information Off.
|
Exercise / conversionHumana Common | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000200 · edgar.xml · nonDerivative · entry 1 LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:31 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000201 · edgar.xml · derivative · entry 8 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,186 Underlying: Humana Common · 1,092 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:31 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Tax withholdingHumana Common | 551 | $206.60 | $113,833.85 |
DisclosureSEC source: 0000049071-16-000201 · edgar.xml · nonDerivative · entry 2 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,260 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:31 UTC |
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
|
Exercise / conversionHumana Common | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000201 · edgar.xml · nonDerivative · entry 1 BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:16 UTC |
Kane Brian ASVP & Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,539 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000199 · edgar.xml · derivative · entry 6 Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,079 Underlying: Humana Common · 1,539 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18 F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:16 UTC |
Kane Brian ASVP & Chief Financial Officer
|
Tax withholdingHumana Common | 541 | $206.60 | $111,767.90 |
DisclosureSEC source: 0000049071-16-000199 · edgar.xml · nonDerivative · entry 2 Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 998 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:16 UTC |
Kane Brian ASVP & Chief Financial Officer
|
Exercise / conversionHumana Common | 1,539 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000199 · edgar.xml · nonDerivative · entry 1 Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:53 UTC |
MURRAY JAMES EEVP & COO
|
Exercise / conversionRestriced Stock Units · Derivative | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000198 · edgar.xml · derivative · entry 12 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,768 Underlying: Humana Common · 2,383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:53 UTC |
MURRAY JAMES EEVP & COO
|
Tax withholdingHumana Common | 1,180 | $206.60 | $243,782.10 |
DisclosureSEC source: 0000049071-16-000198 · edgar.xml · nonDerivative · entry 2 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,441 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:53 UTC |
MURRAY JAMES EEVP & COO
|
Exercise / conversionHumana Common | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000198 · edgar.xml · nonDerivative · entry 1 MURRAY JAMES E · CIK 0001018658 · EVP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:41 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
Exercise / conversionRestricted Stock Units · Derivative | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000197 · edgar.xml · derivative · entry 8 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,186 Underlying: Humana Common · 1,092 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 19:41 UTC |
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
|
Tax withholdingHumana Common | 537 | $206.60 | $110,941.52 |
DisclosureSEC source: 0000049071-16-000197 · edgar.xml · nonDerivative · entry 2 MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,683 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.